Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. - Wikidata - awgldk - TriplyDB

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

http://www.wikidata.org/entity/Q33665767

about

Autoimmune liver serology: current diagnostic and clinical challenges Detection of liver kidney microsomal type 1 antibody using molecularly based immunoassays Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease Type II autoimmune hepatitis: the conundrum of cytochrome P450IID6 Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotyping LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection.Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease Recurrent acute hepatitis associated with use of cetirizine.Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver.The human hepatic cytochromes P450 involved in drug metabolism.Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview.Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.Serum autoantibodies: a road map for the clinical hepatologist.Enzymes as targets for autoantibodies in human autoimmune disease: relevance to pathogenesis?Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?Serum autoantibodies for the diagnosis and management of autoimmune liver diseases.The role of autoantibodies in autoimmune hepatitis type 2.Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine.Autoantibodies in Autoimmune Liver Diseases-Methods of Detection and Interpretation: An Update for the Reporting Pathologist.Possible role of cytochromes P450 in lupus erythematosus and related disorders.Viruses and auto-immune hepatitis.Cytochrome P450 2D6 as a model antigen Autoimmunity in hepatitis C and D virus infection.Recent developments in autoimmune liver diseases.Propranolol oxidation by human liver microsomes--the use of cumene hydroperoxide to probe isoenzyme specificity and regio- and stereoselectivity.The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphism.The CYP2D6 animal model: how to induce autoimmune hepatitis in mice.Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.Conservation of a functionally important surface region between two families of the cytochrome P-450 superfamily.Diversity in mechanisms of substrate oxidation by cytochrome P450 2D6. Lack of an allosteric role of NADPH-cytochrome P450 reductase in catalytic regioselectivity.

P2860

Q24644140-58CAEE76-E6DA-4B84-92FD-24BE1A8CAC8F Q24672941-034762D8-D971-4680-83A5-BAE99904EA8D Q24804699-A09DC579-8E6D-4313-A9B0-30329BB1CC39 Q27473554-640C9B79-B755-4CD7-8A03-3389CC0F0CC8 Q27473555-748DA368-E3FD-421E-8CFD-E3BBF77522C9 Q28069584-DBA1CCD0-053D-4CE6-AE4E-11C2D9688EAA Q28087726-89DDE284-9482-4FF8-9F6A-E68126DFE35F Q30846833-135D92CD-300A-4BED-A660-A48FAEE522E2 Q33921325-0D3827C8-BECE-4B65-BE41-2FC0CDA5CBE0 Q34205552-DC7353CB-2792-4721-A704-24FDAC3275F6 Q34253837-83B701B6-7480-4CC3-8B8E-5B72CF7D8C39 Q34346292-5247CE0C-C05A-44B0-8BB5-B10B6DCCA3B4 Q34408327-54751854-3E69-453E-BD4B-4E93A6C175BB Q34408786-6FCEBF82-C7B2-40C4-A0A1-C3ECD672AC6C Q34551111-31D49F9F-51C1-4406-B9F8-5E652F1D5E8E Q34569386-7EB3B4E5-B831-422C-830B-3BDE9DC33A84 Q35351021-E2A9416F-05E6-46BC-9FA4-7B72DD35BE6B Q35803966-4A51BC2A-C489-4926-8F57-120308C297FD Q36258518-DBF66584-FA77-44E6-BB50-BC1D9C0DF3AD Q36490242-D0B8F0BC-551C-454E-A708-69252D8B4910 Q36699786-A97F0127-228D-4AEB-8C9D-EDC216D1C795 Q36885659-1A0D2B41-CD51-4251-BA0F-2368DC7ADD01 Q37051229-DB179EA0-3D28-4946-9BA0-0C155D175CB3 Q37424696-11075E89-A0DC-4BA9-B6CD-F5B6D0B0CB3B Q37588932-DBE72EA0-027A-4479-B36B-0BE491AB5176 Q38067132-9A527920-7F74-43BF-B2CE-C41D6DFDC7AB Q38085031-8F276988-2FB8-4664-92D8-95EB7505134C Q38634986-9BBC27CE-9BEE-410D-B1AB-8319F80816D7 Q38889147-31D3940A-09F0-450C-95E3-4D5247E0E7ED Q40498843-3887F965-0C32-4D84-8654-624A1A8B4D7E Q40754969-DB470A02-7169-428E-8C4B-4BE62AE1296B Q40988911-A87624E4-9B3F-4C7F-B4F7-7E1A18E8AEE4 Q41115162-AF1E9A15-CDC1-4F52-B6DA-BD4E64F8B600 Q41667301-391F991B-2677-48ED-A0B0-52C2BA0D87D7 Q41775640-A55308F1-05AB-4229-A10E-F26840015FC6 Q41868279-BA4AF3F9-7F93-4FCA-90C2-D8817F0D543B Q42008817-22BC7D66-BC41-4A7A-BFA1-25D53FD8EDE5 Q42792678-F73E1B1A-ECE7-4FE9-AE3B-F20F498FE80E Q42810290-3A60E5BF-1230-4B18-9B34-325B1CDF91A5 Q43710136-9A2AAAD2-C6C9-4D82-9D3E-6B73325B2D84

P2860

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

http://www.wikidata.org/entity/Q33665767

description

1988 nî lūn-bûn

@nan

1988 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

@ast

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

@en

type

label

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

@ast

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

@en

prefLabel

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

@ast

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

@en

P1433

Q33665767-AC2D2EA6-3606-4B6B-BCE3-6A3198D2FEB5

P1476

Q33665767-9A45E88A-59EC-4B39-9F66-03521E699795

P2093

Q33665767-06D16E3B-A018-453A-89E1-A92F22DC6EB3

Q33665767-23380D2F-9D3F-49C2-BF19-08CC4506A75F

Q33665767-63123D53-DF82-4B85-9909-B7DDCA8B2E15

Q33665767-8681B072-579E-467B-A1CF-3AC950BD146A

Q33665767-C96072D9-33F8-4B53-9446-4DE4F1104844

P2860

Q33665767-2A95C2D3-DCAE-47DC-98D8-FD69A66869A0

Q33665767-2DFBDF3A-6374-453D-B6C1-8FEE537BC59A

Q33665767-364C858E-3317-4C70-BEE1-866EC74A3D6E

Q33665767-3BC6DF99-F101-4C4D-AA1D-407ABC9300A8

Q33665767-4A02D68B-14C7-4DC4-9DB2-8C5812075EC9

Q33665767-6BADEE3C-DA79-4B38-A1B8-B01969FEDADE

Q33665767-74EA8F4B-6E68-45E2-AD3A-95B8501B7A45

Q33665767-862C02D0-9992-407D-9695-6AE3D5FB9FDE

Q33665767-8719890C-BFB3-4E5E-8C5D-510113354402

Q33665767-87602A4A-72FA-4DA7-B0F4-A7A8B6B8622F

P304

Q33665767-D13FD4E9-075C-4F37-9136-B2E328E8E2B6

P31

Q33665767-3D0A3292-0FDE-4CB5-8313-F236C68438B1

P356

Q33665767-31E195BF-1547-4E23-AE79-748704EC5306

P407

Q33665767-E1F5AA51-0AED-41FD-8C0C-0A0F8D31F352

P433

Q33665767-9AC7C960-82CB-48B6-8B4F-20B11836F95D

P478

Q33665767-8539F40D-8938-4E70-B3FC-C64C27F2C44B

P577

Q33665767-9ECD6A93-7F2B-4F1B-BF1A-4D5A62E8166D

P5875

Q33665767-DC1C6AD2-92D3-45BD-8211-381851CCE482

P698

Q33665767-DD55285E-ADB8-4060-8971-476F1F1FECA4

P921

Q33665767-0FBFAFB1-0CEB-411A-B9D9-D9CDABA2362E

P932

Q33665767-726B8B1A-5462-4401-A870-3DEB6B4D44DB

P356

PNAS.85.21.8256

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

@en

P2093

Hauri HP

http://www.w3.org/2001/XMLSchema#string

Homberg JC

http://www.w3.org/2001/XMLSchema#string

Loeper J

http://www.w3.org/2001/XMLSchema#string

Meyer UA

http://www.w3.org/2001/XMLSchema#string

Zanger UM

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiency

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Impaired oxidation of debrisoquine in patients with perhexiline neuropathy

A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis

Expression and intracellular transport of microvillus membrane hydrolases in human intestinal epithelial cells

THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.

Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug

P304

8256-8260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.85.21.8256

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

1988-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19969018

http://www.w3.org/2001/XMLSchema#string

P698

3186722

http://www.w3.org/2001/XMLSchema#string

P921

P932

282408

http://www.w3.org/2001/XMLSchema#string